MoneyWorks4Me

Panjon - Quaterly Results

11 Feb 2023 Evaluate
The sales is pegged at Rs. 13.75 millions for the December 2022 quarter. The mentioned figure indicates a decline of about -58.76% as against Rs. 33.34 millions during the year-ago period.Profit after Tax for the quarter ended December 2022 saw a decline of -47.92% from Rs. 0.48 millions to Rs. 0.25  millions.A decline of 0.66 millions was observed in the OP in the quarter ended December 2022 from 1.26 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 13.75 33.34 -58.76 47.90 68.56 -30.13 84.32 145.39 -42.00
Other Income 0.42 0.82 -48.78 1.40 2.46 -43.09 2.97 3.27 -9.17
PBIDT 0.66 1.26 -47.62 2.45 3.58 -31.56 -37.46 5.16 -825.97
Interest 0.10 0.18 -44.44 0.27 0.49 -44.90 0.64 0.98 -34.69
PBDT 0.56 1.08 -48.15 2.18 3.09 -29.45 -38.10 4.18 -1011.48
Depreciation 0.31 0.60 -48.33 0.97 1.70 -42.94 2.03 2.25 -9.78
PBT 0.25 0.48 -47.92 1.21 1.39 -12.95 -40.13 1.93 -2179.27
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.25 0.48 -47.92 1.21 1.39 -12.95 -40.13 1.93 -2179.27
Equity 154.99 154.99 0.00 154.99 154.99 0.00 154.99 154.99 0.00
PBIDTM(%) 4.80 3.78 27.01 5.11 5.22 -2.05 -44.43 3.55 -1351.75
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..